EGFR and non-small cell lung carcinoma: 60 patients with advanced NSCLC with EGFR gene mutation were randomly divided into two groups: The experimental group treated with Fuzheng Zhiai syndrome differentiation herbs + targeted therapy and the control group treated with placebo + targeted therapy.